Clinical trial
An Open, Observational Study to Evaluate the Immunity Persistence of an Inactivated Enterovirus 71 Vaccine (Vero Cell) in Subjects Aged 6 to 71 Months
NCT05397587 is registered in ClinicalTrials.gov with Sinovac Biotech Co., Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open, Observational Study to Evaluate the Immunity Persistence of an Inactivated Enterovirus 71 Vaccine (Vero Cell) in Subjects Aged 6 to 71 Months
- Lead sponsor
- Sinovac Biotech Co., Ltd
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- July 30, 2022
- Completion date
- October 30, 2025
- Enrollment
- 474 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.